List of the 31 European countries whose outputs were examined in this study with their ISO2 codes.

<p>List of the 31 European countries whose outputs were examined in this study with their ISO2 codes.</p

Mean numbers of funding acknowledgments per paper, explicit and implicit, on the basis of integer paper counts (INT) and of fractional counts (FRAC) for the 20 leading European producers of RESPI papers, 2009–13.

<p>Mean numbers of funding acknowledgments per paper, explicit and implicit, on the basis of integer paper counts (INT) and of fractional counts (FRAC) for the 20 leading European producers of RESPI papers, 2009–13.</p

List of leading funders of European respiratory disease research, 2009–13, with fractional counts of numbers of papers (N) and estimates of annual research funding for European papers (€ million).

<p>List of leading funders of European respiratory disease research, 2009–13, with fractional counts of numbers of papers (N) and estimates of annual research funding for European papers (€ million).</p

Citations of European RESPI papers on 45 European respiratory clinical guidelines (CGs), and comparison with research outputs (Res): percentages of EUR31 total.

<p>Citations of European RESPI papers on 45 European respiratory clinical guidelines (CGs), and comparison with research outputs (Res): percentages of EUR31 total.</p

Numbers of RESPI papers in the three main non-communicable respiratory diseases from each of the 18 leading European countries, 2002–13, fractional counts, and their relative commitment (RC) to research on each disease relative to their output in RESPI and to the European average.

<p>Numbers of RESPI papers in the three main non-communicable respiratory diseases from each of the 18 leading European countries, 2002–13, fractional counts, and their relative commitment (RC) to research on each disease relative to their output in RESPI and to the European average.</p

European Union support for respiratory disease research, 2009–13: numbers of papers (left columns) and percent of papers for individual countries (EU, %, right columns).

<p>European Union support for respiratory disease research, 2009–13: numbers of papers (left columns) and percent of papers for individual countries (EU, %, right columns).</p

Incidence of cystic fibrosis in selected European countries [36].

<p>Incidence of cystic fibrosis in selected European countries [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0154197#pone.0154197.ref036" target="_blank">36</a>].</p

Main sectors supporting respiratory disease research in 11 leading European countries, 2009–13.

<p>GOV = public sector (including local authorities), PNP = private-non-profit, CEC = European Union, INDY = industry (mainly pharma).</p

Trends in median (interquartile range) five year running actual citation index [ACI] counts per publication, stratified by World Bank income group status (1999–2008).

<p>ACI is calculated by dividing a publication's total citations five years post-publication by five. Lower citation counts in 2008 may reflect incomplete citations reported to <u>Web of Knowledge</u> during follow-up period (2012).</p

Country-level fractional counts against logarithmic annual citation counts in 1999 (A) and 2008 (B).

<p>Country-level fractional counts (scale: 0–1) against logarithmic annual citation counts (country-level cardiovascular research output) with color coding representing World Bank country income status. Fractional counts represent the proportion of each country's authors against the total number of authors on each publication. The size of each country's bubble represents the population size of that country. Average citation index (ACI) is calculated by dividing a publication's total citations five years post-publication by five.</p